NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)
$30.41 0.15 (0.4957%)
Analysed NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) News Sources
NewAmsterdam Pharma Sets PREVAIL Interim Analysis for Q4 2026 on Encouraging Blinded Trends
08-05-2026
marketbeat.com
Do NewAmsterdam Pharma’s (NAMS) Dilution Plans Reframe Its Path to Funding Ongoing Losses?
08-05-2026
yahoo.com
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
11-05-2026
yahoo.com
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
11-05-2026
yahoo.com
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
28-05-2026
yahoo.com
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
30-05-2026
fool.com
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
30-05-2026
fool.com
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
03-06-2026
yahoo.com
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026
08-06-2026
yahoo.com
A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness
11-06-2026
yahoo.com
What is the current price of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)?
The current price of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) is $30.41.
NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) since the previous trading day is $0.15.
NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) since the previous trading day is 0.4957%.
What is the most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)?
The most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)?
The most recent sentiment for NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ) is .
SEC-8K** Filing Available For NEWAMSTERDAM PHARMA CO NV (NAMS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.